A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

PHASE1RecruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

June 8, 2027

Study Completion Date

August 10, 2031

Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG

BAY3546828

Intravenous (IV) infusion on Day 1 of each cycle.

Trial Locations (32)

4056

NOT_YET_RECRUITING

Universitätsspital Basel, Basel

5404

NOT_YET_RECRUITING

Kantonsspital Baden, Baden

8091

NOT_YET_RECRUITING

Univestitätsspital Zürich (USZ), Zurich

17176

SUSPENDED

Karolinska Universitetssjukhuset - Fas I-enheten Solna CKC, Stockholm

20141

SUSPENDED

Istituto Europeo di Oncologia s.r.l - Medicina Nucleare, Milan

20520

RECRUITING

CRST Clinical Research Services Turku, Turku

22185

SUSPENDED

Skånes Universitetssjukhus Lund - Onkologens kliniska forskningsenhet, Lund

33520

SUSPENDED

Tampere University Hospital, Tampere

41346

SUSPENDED

Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH, Gothenburg

55455

NOT_YET_RECRUITING

M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center, Minneapolis

68130

NOT_YET_RECRUITING

XCancer Omaha, Omaha

70210

RECRUITING

Kuopio University Hospital, Kuopio

75185

SUSPENDED

Akademiska Sjukhuset - Fas-I-enheten, Uppsala

77030

NOT_YET_RECRUITING

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

80131

SUSPENDED

IRCCS Istituto Nazionale Tumori Fondazione Pascale - S. C. Medicina Nucleare e Terapia Metabolica, Napoli

91010

NOT_YET_RECRUITING

City of Hope - Duarte Cancer Center, Duarte

84106-1494

NOT_YET_RECRUITING

Utah Cancer Specialists (UCS) (Intermountain Hematology - Oncology Associates) - UCS Cancer Center, Salt Lake City

T6G 1Z2

SUSPENDED

Cross Cancer Institute, Clinical Trials Unit, Edmonton

V5Z 4E6

SUSPENDED

BC Cancer - Vancouver Site, Vancouver

L8V 5C2

SUSPENDED

Juravinski Cancer Centre - Clinical Trials Department, Hamilton

M5G 2C4

SUSPENDED

Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology, Toronto

H2X 3E4

NOT_YET_RECRUITING

Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopi, Montreal

H4A 3J1

ACTIVE_NOT_RECRUITING

McGill University Health Centre (MUHC) - Research Institute (RI) - McConnell Centre for Innovative Medicine (CIM), Montreal

J1H 5N4

NOT_YET_RECRUITING

Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hopital Fleurimont, Sherbrooke

00029

RECRUITING

HUS, Meilahden sairaala, Helsinki

FIN-00180

RECRUITING

Docrates Mehiläinen Syöpäsairaala, Helsinki

9713 GZ

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

3015 CE

RECRUITING

Erasmus Medisch Centrum, Rotterdam

Cambridgeshire

RECRUITING

"Cambridge University Hospitals NHS Foundation Trust , Addenbrookes Hospital - Clinical Research Centre"

Surrey

RECRUITING

"The Royal Marsden NHS Foundation Trust , Sutton - Oak Foundation Drug Development Unit"

Unknown

RECRUITING

"University College London Hospitals NHS Foundation Trust , University College Hospital - NIHR UCLH Clinical Research Facility"

SUSPENDED

"The Newcastle upon Tyne Hospitals NHS Foundation Trust , Freeman Hospital - Cancer Trials Research Centre"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06052306 - A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) | Biotech Hunter | Biotech Hunter